Novel Model of Integrated Care of Older Patients With Atrial Fibrillation and Heart Failure in Rural China (MIRACLE-AFHF)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-80
SponsorJiangsu Taizhou People's Hospital

About this trial

This cluster randomization study aims to compare village-doctor led integrated care versus usual care to improve heart failure risk management, guideline-directed medical therapy, self-management adherence, and clinical outcomes for older patients with atrial fibrillation and heart failure in rural China.

Eligibility criteria

Qualifiers

None

Disqualifiers

Expected life expectancy of less than 12 months.

Severe renal insufficiency (Ccr < 30ml/min) or ongoing dialysis treatment.

Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.

Indications for pacemaker implantation without having undergone implantation.

Trial design

Treatments tested in this trial

  • Village-Doctor Led Integrated Care
  • Usual Care

Treatment groups

942 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Jiangsu Taizhou People's Hospital

Lead sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborator